Production (Stage)
Entera Bio Ltd.
ENTX
$1.86
-$0.23-11.01%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -8.86% | 21.95% | -40.84% | -6.35% | -1.10% |
| Total Depreciation and Amortization | -27.27% | 0.00% | 0.00% | -15.38% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.56% | -37.23% | 57.17% | 30.33% | 34.62% |
| Change in Net Operating Assets | 88.14% | 488.16% | -136.89% | 165.81% | 67.83% |
| Cash from Operations | 4.29% | 31.89% | -61.35% | 28.30% | 28.85% |
| Capital Expenditure | -166.67% | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -166.67% | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 282.01% | 27,130.77% | -98.93% | 3,953.33% | -99.55% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 42.41% | -- | -- | -- | -- |
| Cash from Financing | 314.58% | 24,646.15% | -98.93% | 3,953.33% | -99.50% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 582.60% | 181.60% | -1,699.16% | 93.50% | -153.74% |